Danaher steps up AI push in life sciences

US company applauds China's progress in pharmaceuticals, medical devices

Acknowledging the rapid development of the artificial intelligence sector in China, US life sciences company Danaher Corp is expecting further cooperation in combining AI with life sciences and will continue to invest in the country, a senior executive said.

Lan Jun, general manager of Agela &Phenomenex China, an operating company of Danaher, said during a recent forum in Tianjin:"'China Speed' never goes out of style. Over the last two decades, China has been a pioneer in manufacturing. Now, in the era of new technology, the country is still playing a leading role."

In recent years, China has made significant progress in the smart industry, particularly in the pharmaceutical and medical devices sectors, he said.